Manage stand orders
Select Option
Manufacturers

Analis sa/nv

Rue de Neverlée 11, 5020 Suarlée (Namur)
Belgium

This company is co-exhibitor of
AWEX - Wallonia Export & Investment

Contact

Ron ROOBROECK

Phone
+32 476 57 71 08

Email
ron.roobroeck@analis.be

Filip HENDRICKX

Phone
+32 498565056

Email
filip.hendrickx@analis.be

Visit us

Unsettled / NN

16.11.2020

Topic

all-day

Disinfecting hand and surfaces? It's not enough

Hospital-acquired infection (HAI) is one of the leading clinical burdens worldwide. In the United States, roughly 1.7 million hospital-associated infections occur, from all types of micro-organisms, leading or contributing to roughly 99,000 deaths each year.

Analis, already expert in disinfection products with its Hymetec products, offers you a wider disinfection product portfolio to prevent nosocomial infections, thanks to its NEW PARTNERSHIP with Novaerus and Decon-X.

More information on : https://analis.be/en-us/disinfection/

More Less

17.11.2020

Topic

all-day

Disinfecting hand and surfaces? It's not enough

Hospital-acquired infection (HAI) is one of the leading clinical burdens worldwide. In the United States, roughly 1.7 million hospital-associated infections occur, from all types of micro-organisms, leading or contributing to roughly 99,000 deaths each year.

Analis, already expert in disinfection products with its Hymetec products, offers you a wider disinfection product portfolio to prevent nosocomial infections, thanks to its NEW PARTNERSHIP with Novaerus and Decon-X.

More information on : https://analis.be/en-us/disinfection/

More Less

18.11.2020

Topic

all-day

Novaerus Defend 1050 Proven to Reduce SARS-CoV-2 by 99.99%

“To successfully control the spread of pathogens and viruses, we need to close the infection control loop; hands, surfaces and air.” Dr Kevin Devlin, CEO at WellAir, the parent company of Novaerus.

Research suggest that disinfecting air plays a role in preventing the spread of SARS-CoV-2. While respiratory droplets are considered the primary transmission route, aerosols are being considered by many health authorities as a possible mode of infection transmission. This is also published in a recent paper by a Dutch group in the The Lancet Respiratory Medicine.

The air dis-infection device the Novaerus Defend 1050 has been independently tested and shown effective at reducing MS2 Bacteriophage, a surrogate for SARS-CoV-2, by 99.99% in 15 minutes. This is the conclusion from the Aerosol Research and Engineering (ARE) Laboratories.

The Novaerus Defend 1050 combines rapid air dis-infection and purification into one device. It uses a patented ultra-low energy plasma technology combined with a triple-stage filtration system from Camfil®. This is a non-selective, rapid killing technology, it offers a unique and safe solution to kill airborne viruses 24/7, reducing the risk of disease and infectious outbreaks.

Analis is the BeNeLux partner for Novaerus air disinfection devices. More information on www.analis.be/disinfection

More Less

Our range of products

Product categories

  • 01  Electromedical equipment / medical technology
  • 01.10  Hygiene / sterilisation / disinfection
  • 01.10.01  Sterilisation equipment, disinfection equipment and accessories, autoclaves

Sterilisation equipment, disinfection equipment and accessories, autoclaves

  • 01  Electromedical equipment / medical technology
  • 01.10  Hygiene / sterilisation / disinfection
  • 01.10.06  Air processing systems, air purification systems, disinfection systems

Air processing systems, air purification systems, disinfection systems

Company news

Date

Topic

Download

Sep 2, 2020

Hymetec Disinfecting Solutions

Cleaning & Disinfecting technologies and solutions for rapid disinfection by pulverization techniques (for medical devices,tables or any surface).
HyPro medical 3% H202 & HyPro technical 7 % H202 are disinfectant solutions intended for disinfecting the surfaces of non-invasive medical devices and equipment.

More Less

Sep 2, 2020

Disinfecting hand and surfaces? It's not enough

Hospital-acquired infection (HAI) is one of the leading clinical burdens worldwide. In the United States, roughly 1.7 million hospital-associated infections occur, from all types of micro-organisms, leading or contributing to roughly 99,000 deaths each year.

Analis, already expert in disinfection products with its Hymetec products, offers you a wider disinfection product portfolio to prevent nosocomial infections, thanks to its NEW PARTNERSHIP with Novaerus and Decon-X.

More Less

Sep 2, 2020

Novaerus Defend 1050 Proven to Reduce SARS-CoV-2 by 99.99%

“To successfully control the spread of pathogens and viruses, we need to close the infection control loop; hands, surfaces and air.” Dr Kevin Devlin, CEO at WellAir, the parent company of Novaerus.

Research suggest that disinfecting air plays a role in preventing the spread of SARS-CoV-2. While respiratory droplets are considered the primary transmission route, aerosols are being considered by many health authorities as a possible mode of infection transmission. This is also published in a recent paper by a Dutch group in the The Lancet Respiratory Medicine.

The air dis-infection device the Novaerus Defend 1050 has been independently tested and shown effective at reducing MS2 Bacteriophage, a surrogate for SARS-CoV-2, by 99.99% in 15 minutes. This is the conclusion from the Aerosol Research and Engineering (ARE) Laboratories. 

The Novaerus Defend 1050 combines rapid air dis-infection and purification into one device. It uses a patented ultra-low energy plasma technology combined with a triple-stage filtration system from Camfil®.  This is a non-selective, rapid killing technology, it offers a unique and safe solution to kill airborne viruses 24/7, reducing the risk of disease and infectious outbreaks.

Analis is the BeNeLux partner for Novaerus air disinfection devices. More information on www.analis.be/disinfection

More Less

About us

Company details

As a distributor and manufacturer of scientific instruments for laboratories and lab furniture, ANALIS sa/nv is a renowned company in the Benelux countries. Established in 1927, Analis is headquartered in Namur (Belgium South) and has branch offices in Gent (Belgium North) and Amsterdam (The Netherlands) .

In each application field such as pharma, life science & biotechnology, cell analysis, chemical analysis, medical in vitro diagnosis and industrial QC/QA, we have specialized teams that can prodive their expertise and will discuss your laboratory projects with you.

Analis, has a specific department specialized in disinfection solutions.  This unit offers a wide range of instruments & solutions for air, room & surface disinfection :

- HYMETEC:  H202 disinfectant solutions intended for disinfecting the surfaces of non-invasive medical devices and equipment. Hyspray,  a nebulizing appliance that rapidly disinfects rooms and surfaces by using the H202 HyPro technical solution.

-NOVAERUS: disinfection equipment to reduce infection by destroying pathogens in the air with the patented Nanostrike ultra-low energy plasma technology.

-DeconX : Fully automated, wireless monitoring, sensor driven, system that removes bacteria, viruses and spores from the air, surfaces and equipment (H202 decontamination).


ASK MORE INFORMATION DISINFECTION@ANALIS.BE

WWW.DISINFECTION.BE

More Less

Company data

Number of employees

100-499

Foundation

1927

Area of business

Laboratory Equipment

Company information as a PDF file